DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS: DMKPQ · Delayed Price · USD
0.0700
0.00 (0.00%)
Mar 26, 2024, 12:00 AM EDT - Market closed

DMK Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520132012 2011 - 1994
Revenue
4.762.212.7822.1115.0913.076.47000
Upgrade
Revenue Growth (YoY)
115.34%-20.45%-87.44%46.58%15.40%101.94%----
Upgrade
Cost of Revenue
6.196.876.3315.489.87.424.85000
Upgrade
Gross Profit
-1.43-4.66-3.556.645.295.651.62000
Upgrade
Selling, General & Admin
13.2516.1420.0925.2925.9522.8217.139.013.392.01
Upgrade
Research & Development
10.3811.268.0410.3818.797.539.74.841.011.21
Upgrade
Other Operating Expenses
004.660.320.0100000
Upgrade
Operating Expenses
23.6327.4132.7935.9944.7530.3526.8213.854.43.22
Upgrade
Operating Income
-25.06-32.07-36.34-29.35-39.46-24.69-25.2-13.85-4.4-3.22
Upgrade
Interest Expense / Income
-0.040.0100.120.160.230.2108.632.33
Upgrade
Other Expense / Income
1.4613.7513.04-1.97-0.250.95-1.41-0.28-4.871.64
Upgrade
Pretax Income
-26.48-45.83-49.39-27.5-39.38-25.88-24.01-13.57-8.16-7.19
Upgrade
Income Tax
0000.01-0.37-0.34-4.57000
Upgrade
Net Income
-26.48-45.83-49.39-27.51-39.01-25.54-19.44-13.57-8.16-7.19
Upgrade
Preferred Dividends
0000001.37000
Upgrade
Net Income Common
-26.48-45.83-49.39-27.51-39.01-25.54-20.81-13.57-8.16-7.19
Upgrade
Shares Outstanding (Basic)
2211100000
Upgrade
Shares Outstanding (Diluted)
2211100000
Upgrade
Shares Change
3.95%85.84%45.63%36.28%37.87%61.99%30.25%79.32%27.89%11.31%
Upgrade
EPS (Basic)
-12.60-22.40-44.80-36.40-70.00-63.00-83.30-71.40-77.70-86.10
Upgrade
EPS (Diluted)
-12.60-22.40-44.80-36.40-70.00-63.00-83.30-72.10-85.40-86.10
Upgrade
Free Cash Flow
-26.58-39.01-21.35-22.75-36.19-17.19-21.28-10.34-6.88-2.56
Upgrade
Free Cash Flow Per Share
-12.42-18.94-19.27-29.90-64.82-42.46-85.12-54.50-65.53-30.57
Upgrade
Gross Margin
-30.10%-211.14%-127.87%30.00%35.06%43.24%25.03%---
Upgrade
Operating Margin
-526.88%-1451.97%-1308.89%-132.72%-261.58%-188.88%-389.32%---
Upgrade
Profit Margin
-556.72%-2074.91%-1778.84%-124.41%-258.55%-195.35%-321.46%---
Upgrade
Free Cash Flow Margin
-558.88%-1766.16%-769.00%-102.89%-239.90%-131.53%-328.72%---
Upgrade
EBITDA
-25.04-44.39-47.05-24.42-36.12-22.58-21.26-12.580.77-4.86
Upgrade
EBITDA Margin
-526.42%-2009.57%-1694.69%-110.42%-239.41%-172.75%-328.44%---
Upgrade
Depreciation & Amortization
1.481.442.332.963.13.062.530.990.30
Upgrade
EBIT
-26.52-45.82-49.38-27.38-39.22-25.65-23.8-13.570.47-4.86
Upgrade
EBIT Margin
-557.61%-2074.58%-1778.58%-123.82%-259.95%-196.18%-367.59%---
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).